Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 7Colorectal Neoplasms 7Neoplasms 6Breast Neoplasms 6Lung Neoplasms 4Uterine Cervical Dysplasia 2Prostatic Neoplasms 2Papillomavirus Infections 2End Stage Liver Disease 2Warts 1Urinary Bladder Neoplasms 1Tinea 1Smoking 1Skin Neoplasms 1Pancreatic Neoplasms 1Nevus 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Molluscum Contagiosum 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Cancer Screening 1Liver Neoplasms 1Kidney Failure, Chronic 1Keratosis, Actinic 1Intestinal Neoplasms 1Impetigo 1Herpes Zoster 1Hepatitis C 1Heart Diseases 1

Interventions

Gemcitabine 677130-nm albumin-bound paclitaxel 197Fluorouracil 184Oxaliplatin 173Albumin-Bound Paclitaxel 151Capecitabine 137Leucovorin 129Irinotecan 111Radiotherapy 95Taxes 83pembrolizumab 80Cisplatin 71Erlotinib Hydrochloride 69Radiosurgery 67Nivolumab 56Bevacizumab 54Drug Therapy 52Cyclophosphamide 48Magnetic Resonance Spectroscopy 45folfirinox 42Docetaxel 41Cetuximab 40irinotecan sucrosofate 36Specimen Handling 36S 1 (combination) 36Biopsy 30Radiation 29Paclitaxel 29Ipilimumab 27Surgical Procedures, Operative 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neoplasms × Mass Screening × Clear all
NCT00837135 2016-08-17

GI-4000 With Adoptive Transfer in Pancreatic Cancer

University of Pennsylvania

Phase 1 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡